Ropivacaine;Ropivacaina

Revista Espanola de Anestesiologia y Reanimacion

Volumn 46, Issue 10, 1999, Pages 453-459

  Aguilar, J L ^a   Mendiola, M A ^a   Pedrero, A ^a  

^a Hospital de Cruz Roja Espanõla   (Spain)

Author keywords

Amides; Anesthetics, local; Pharmacology; Ropivacaine

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; ROPIVACAINE; AMIDE;

CARDIOTOXICITY; CHEMICAL STRUCTURE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; EPIDURAL ANESTHESIA; HEART; HUMAN; INTRAVENOUS REGIONAL ANESTHESIA; META ANALYSIS; MOTOR NERVE BLOCK; NEUROTOXICITY; PERIBULBAR ANESTHESIA; RETROBULBAR ANESTHESIA; REVIEW; ANIMAL;

AMIDES; ANESTHETICS, LOCAL; ANIMALS; HUMANS;

EID: 0033402889     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Akerman B, Hellberg IB, Trossvik C. Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988; 32: 571-578.
2. Bader AM, Datta S, Flanagan H, Covino BG. Comparison of bupivacaine and ropivacaine conduction blockade in the isolated rabbit vagus nerve. Anesth Analg 1989; 68: 724-727.
3. Tuttle AA, Katz JA, Bridenbaugh PO, Quinlan R, Knarr D. A double-blind comparison of the abdominal wall relaxation produced by epidural 0,75% ropivacaine and 0,75% bupivacaine in gynecologic surgery. Reg Anesth 1995; 20: 515-520.
4. Dyhre H, Lang M, Wallin R, Renck H. The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in the rat. Acta Anaesthesiol Scand 1997; 41: 1.346-1.352.
5. Emanuelsson BM, Persson J, Aim C, Heller A, Gustafsson LL. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology 1997; 87: 1.309-1.317.
6. Kerkamp HE, Gielen MJM, Edström HH. Comparison of 0.75% ropivacaine with epinefrine and 0.75% bupivacaine with epinefrine in lumbar anesthesia. Reg Anesth 1990; 15: 204-207.
7. Feldman HS, Covino BG. Comparive motor-blocking effects of bupivacaine and ropivacaine, a new amide local anesthetic, in the rat and the dog. Anesth Analg 1988; 67: 1.047-1.052.
8. Nolte H, Fruhstorfer H, Edstrom HA. Local anesthetic efficacy of ropivacaine (LEA 103) in ulnar nerve block. Reg Anesth 1990; 15: 118-124.
9. Zaric D, Axelsson K, Nydahl PA, Philipson L, Larsson P, Jansson JR. Sensory and motor blockade during epidural analgesia with 1%, 0.15% and 0.5% ropivacaine: a double-blind study. Anesth Analg 1991; 72: 509-515.
10. Cederholm I. Preliminary risk-benefit analysis of ropivacaine in labour and following surgery. Drug Saf 1997; 16: 391-402.
11. Rosenberg PH, Kytta J, Alila A. Absortion of bupivacaine, etidocaine, lignocaine and ropivacaine into n-heptane, rat sciatic nerve, and human extradural and subcutaneous fat. Br J Anaesth 1986; 58: 310-314.
12. Datta S, Camann W, Bader A, Vanderburgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology 1995; 82:1.346-1.352.
13. Rutten AJ, Mather LE, Nancarrow C, Sloan PA, McLean CF. Cardiovascular effects and regional clearances of intravenous ropivacaine in sheep. Anesth Analg 1990; 70: 577-582.
14. Knuth S, Perkins G, Daday F. Postoperative epidural ropivacaine. Anaesth Intensive Care 1997; 25: 435-437
15. Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S et al. Metabolism and excretion of ropivacaine in humans. Drug Metab Dispos 1996; 27: 962-968.
16. Wang GK. Binding affinity and estereoselectivity of local anesthetic in single batrachotoxin activated Na+ channels. J Gen Physiol 1990; 96: 1.105-1.127.
17. Hassan HG, Renck H, Akerman B, youssef H. On the relative potency of amino-amide local anesthetics in vivo. Acta Anaesthesiol Scand 1994; 38: 505-509.
18. max). Pharmacol Toxicol 1988; 63: 96-104.
19. Valenzuela C, Delpon E, Franqueza L, Gay P, Snyders DJ, Tamargo J. Effects of ropivacaine on a potassium channel (hKv 1.5) cloned from human ventricle. Anesthesiology 1997; 86: 718-728.
20. Zhang X, Ji A, Lee C. The effects of bupivacaine and ropivacaine on cardiomyocyte contractility and excitability in rats. Anesthesiology 1998; 89: A831.
21. Pitkanen M. Feldman HS, Arthur GR, Covino BG. Chronotropic and inotropic effects of ropivacaine, bupivacaine and lidocaine in the spontaneously beating and electrically paced isolated perfused rabbit heart. Reg Anesth 1992; 17: 183-192.
22. Reiz S, Häggmark S, Johansson G, Nath S. Cardiotoxicity of ropivacaine-a new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93-98.
23. Hurley RJ, Feldman HS, Latka C, Arthur GR, Covino BG. The effects of epinefrine on the anesthetic and hemodynamic properties of ropivacaine and bupivacine after epidural administration in the dog. Reg Anesth 1991; 16: 303-307.
24. Feldman HS, Arthur GR, Pitkanen M, Hurley R, Doucette AM, Covino BG. Treatment of acute systemic toxicity after rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991; 73: 373-384.
25. Morishima HO, Pedersen H, Finster M, Hiraoka H, Tsuji A, Feldman HS et al. Bupivacaine toxicity in pregnat and nonpregnant ewes. Anesthesioogy 1985; 63: 134-139.
26. Santos AC, Arthur GR, Pedersen H, Morishima O, Finster M, COVINO BG. Systemic toxicity of ropivacaine during ovine pregnancy. Anesthesiology 1991; 75: 137-141.
27. Danielsson BR, Danielson MK, Boo EL, Arvidsson T, Halldin MM. Toxicity of bupivacaine and ropivacaine in relation to free plasma concentrations in pregnant rats: a comparative study. Pharmacol Toxicol 1997; 81: 90-96.
28. Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in the conscious dog. Anesth Analg 1989; 69: 794-801.
29. Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569.
30. McClure JH, Ropivacaine. Br J Anaesth 1996; 76: 300-307.
31. Aps C, Reynolds F. An intradermal study of the local aaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol 1978; 6: 63-68.
32. Brockway M, Bannister J, McClure JH, McKeown D, Wildsmith JAW. Comparisom of extradural ropivacaine and bupivacaine. Br J Anaesth 1991; 66: 31-37.
33. Lee A, Fagan D, Lamont M, Tucker GT; Halldin M; Scott DB. Disposition kinetics of ropivacaine in humans. Anesth Analg 1989; 69: 736-738.
34. Kopacz DJ, Emanuelsson BM, Thompson GE, CArpenter RL, Stephenson CA. Pharmacokinetics of ropivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology 1994; 81: 1.139-1.148.
35. Vainionpaa VA, Haavisto ET, Huha TM, Korpi KJ, Nuutinen LS, Hollmen AI et al. A clinical and pharmacokinetic comparison of ropivacaine and bupivacaine in axillary plexus block. Anesth Analg 1995; 81: 534-538.
36. Concepcion M, Arthur GR, Steele SM, Bader AM. A new local anesthetic ropivacaine. Its epidural effects in humans. Anesth Analg 1990; 70: 80-85.
37. Katz JA, Bridenbaugh PO, Knarr DC, Helton SH, Denson DD. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans. Anesth Analg 1990; 70: 16-21.
38. Morrison LMM, Emanuelsson BM, McClure JH, Pollok AJ, McKeown DW, Brockway M et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. BrJ Anesth 1994; 72: 164-169.
39. Cederholm I, Akerman B, Evers H. Local analgesic and vascular effects of intradermal ropivacaine and bupivacaine in various concentrations with and without addition of adrenaline in man. Acta Anaesthesiol Scand 1994; 38: 322-327.
40. Morton CP, Bloomfield S, Magnusson A, Jozwiak H, McClure JH. Ropivacaine 0.75% for extradural anaesthesia in elective caesarean section: an open clinical and pharmacokinetic study in mother and neonate. Br J Anaesth 1997; 79: 3-8.
41. Plowman AN, Bolsin S, Mather LE. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride. Anaesth Intensive Care 1998; 26: 204-206.
42. Zaric D, Nydahl PA, Philipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: a double-blind study. Reg Anesth 1996; 21: 14-25.
43. Zaric D, Nydahl PA, Adel SO, Enbom M, Magnusson M, Philipson L et al. The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) on nerve conduction velocity and postural control in volunteers. Acta Anaesthesiol Scand 1996; 40: 342-349.
44. Owen MD, D'Angelo R, Gerancher JC, Thompson JM, Foss ML, Babb JD et al. 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth Analg 1998; 86: 527-531.
45. Gaiser RR, Venkateswaren P, Cheek TG, Persiley E, Buxbaum J, Hedge J et al. Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery. J Clin Anesth 1997; 9: 564-568.
46. Eddleston JM, Holland JJ, Griffin RP. Corbert A, Horsman EL, Reynolds F. A double mine comparison of 0.25% ropivacaine and 0.25% bupivacaine for extradural analgesia in labor. Br J Anaesth 1996; 76: 66-71.
47. Mair HA, Writer D, Douglas J, Weeks S, Gambling D, McArthur A. Double-blind comparison of epidural ropivacaine 0.25% and bupivacaine 0.25% for the relief of childbirth pain. Can J Anaesth 1997; 44: 599-604.
48. Benhamou D, Hamza J, Eledjam JJ, Dailland P, Palot M. Seebacher J et al. Continuous extradural infusion of ropivacaine 2 mg ml-1 for pain relief during labour. Br J Anaesth 1997; 78: 748-750.
49. Alahuhta S. Räsänen J, Jouppila P, Kangas T, Jouppila R, Westerling P et al. The effects of epidural ropivacaine and bupivacaine for Caesarean section on uteroplacental and fetal circulation. Anesthesiology 1995; 83: 23-32.
50. Irestedt L, Emanuelsson BM, Ekblom A, Olofsson C, Reventlid H. Ropivacaine 7.5 mg/ml for elective cesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg. Acta Anesthesiol Scand 1997; 41: 1.149-1.156.
51. Crosby E, Sandler A, Finucane B, Writer D, Reid D, McKenna J et al. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarean section. Can J Anaesth 1998; 45:1.066-1.071.
52. Scott DA, Emanuelsson BM, Mooney PH, Cook RJ. Junestrand C. Pharmacokinetics and efficacy of long term epidural ropivacaine infusion for posoperative analgesia. Anesth Analg 1997; 85: 1.322-1.330.
53. Badner NH, Reid D, Sullivan P, Ganapathy S, Crosby E. McKenna J et al. Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery: a dose-finding study. Can J Anaesth 1996; 43: 17-22.
54. Liu SS, Moore JM, Luo AM, Trautman WJ, Carpenter RL. Comparison of three solutions of ropivacaine/fentanyl for postoperative patient-controlled epidural analgesia. Anesthesiology 1999; 90: 727-733.
55. Fattorini F, Pascarella MA, Rinaldi F, Benvenuti SG, Ricci Z, Romagnoli S. Peridural analgesic therapy in orthopedic surgery: comparison of ropivacaine and bupivacaine. Clin Ther 1997; 148: 623-625.
56. McGlade DP, Kalpohas MV, Mooney PH, Buckland MR, Vallipuram SK, Hendrata MV et al. Comparison of 0.5% ropivacaine and 0.5% bupivacaine in lumbar epidural anaesthesia for lower limb orthopaedic-surgery. Anaesth Intensive Care 1997; 25: 262-266.
57. Brodner G, Mertes N, Van Aken H, Pogatzki E, Buerkle H, Marcus MA et al. Epidural analgesia with local anesthetics after abdominal surgery: earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine. Anesth Analg 1999; 88: 128-133.
58. Finucane BT, Sandler AN, McKenna J, Reid D, Milner AL, Friedlander et al. A double blinc comparison of ropivacaine 0.5%, 0.75%, 1% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy. Can J Anaesth 1996; 43: 442-449.
59. Schug SA, Scott DA, Payne J, Mooney PH, Hagglof B. Postoperative analgesia by continuous extradural infusion of ropivacaine after upper abdominal surgery. Br J Anaesth 1996; 76: 487-491.
60. Markham A, Fau ds D. Ropivacaine. A review of its pharmacology and therapeutic use in regional anaesthesia. Drugs 1996; 52: 429-449.
61. Fattorini F, Pascarella MA, Benvenuti SG, Ricci Z, Ricciardi L, Rinaldi F et al. Use of ropivacaine in axillary brachial plexus block. Clin Ther 1997; 148: 527-530.
62. Korman B, Riley RH. Convulsions induced by ropivacaine during interscalene brachial plexus block. Anesth Analg 1997; 85: 1.128-1.129.
63. Borgeat A, Ruetsch YA, Jorg M. Convulsions induced by ropivacaine during interscalene brachial plexus block. Anesth Analg 1998; 87: 497.
64. Fanelli G, Casati A, Beccaria P, Aldegheri G, Berti M, Tarantino F et al. A double-blind comparison of ropivacaine, bupivacaine and mepivacaine during sciatic and femoral nerve blockade. Anesth Analg 1998; 87: 597-600.
65. Ivani G, Mereto N, Lampugnani E, Negri PD, Torre M, Mattiolo G et al. Ropivacaine in paediatric surgery: preliminary results. Paediatr Anaesth 1998; 8: 127-129.
66. Da Conceicao MJ, Coelho L, Caudal anaesthesia with 0.375% ropivacaine or 0.375% bapivacaine in paediatric patients. Br J Anaesth 1998; 80: 507-508.
67. Johansson B. Hallerback B, Stubberod A, Janbu T, Edwin B, Glise H et al. Preoperative local infiltration with ropivacaine for postoperative pain relief after inguinal hernia repair. A randomised controlled trial. Eur J Surg 1997; 163: 371-378.
68. Pettersson N, Emanuelsson BM, Reventlid H, Hahn RG. High-dose ropivacaine wound infiltration for pain relief after inguinal hernia repair. Reg Anesth Pain Med 1998; 23: 189-196.
69. Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg 1996; 82: 636-640.
70. Wahedi W, Nolte H, Klein P Ropivacaine for spinal anesthesia. A dose-finding study. Anaesthesist 1996; 45: 737-744.
71. Levin A, Datta S, Camann WR Intrathecal ropivacaine for labor analgesia: a comparison with bupivacaine. Anesth Analg 1998; 87: 624-627.
72. Kshatri AM, McGarrity SJ, Hahn MB Patient-controlled analgesia using ropivacaine via an intrathecal catheter. Reg Anesth Pain Med 1998; 23: 320-322
73. Martinsson T, Haegerstrand A, Dalsgaard CJ. Effects of ropivacaine on cicosanoid release from human granulocytes and endothelial cells in vitro. Inflamm Res 1997; 46: 398-403.
74. Arlander E, Ost A, Stahlberg D, Lofberg R. Ropivacaine gel in active distal ulcerative colitis and proctitis - a pharmacokinetic and exploratory clinical study. Aliment Pharmacol Ther 1996; 10: 73-81.
75. Hartmannsgruber MWB, Atanassoff PG, Schroeter S, Bobart VAS, Silverman DG. Does the addition of ketorolac to ropivacaine improve tourniquet tolerance? A volunteer study. Anesthesiology 1998; 89: A890.
76. Gillart T, Barrau P, Bazin J, Roche G, Chiambaretta F, Schoeffler P. Comparison of lidocaine + ropivacaine vs lidocaine + bupivacaine for single medial injection peribulbar anesthesia. Anesthesiology 1998; 89: A854.
77. Fulling PD, Peterfreund RA. Alkalinization of ropivacaine with sodium bicarbonate: pH adjustment and precipitation characteristics. Anesthesiology 1998; 89: A844.
78. Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine and bupivacaine with or without epinephrine in rats. Acta Anaesthesiol Scand 1998; 42: 685-690.
79. Levin A, Natale M, Datta S, Caamnn WR. Intrathecal ropivacaine plus sufentanil compared with intrathecal bupivacaine plus sufentanil for labor analgesia. Anesthesiology 1998; 98: A1.
80. Klein SM, D'Ercole FJ, Steele SM, Barton A, Gleason DH, Shinier CL et a . A comparison of ropivacaine 0,5%, bupivacaine 0,5% and ropivacaine 0,75% for interescalene nerve block. Anesthesiology 1998; 89: A884.
81. Horn EP, Schroeder F, Wilhelm S, Uebe B, Sessler DI. Standl TH et al. Ropivacaine wound infiltration in patients following major shoulder surgery. Anesthesiology 1998; 89: A878.